A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway

Background/Aims: The roles and related mechanisms of RNA binding protein FUS (fused in sarcoma/translocated in liposarcoma) are unclear in numerous cancers, including hepatocellular carcinoma (HCC). Methods: Quantitative reverse transcription PCR (qRT-PCR), western blot, cell viability, transwell mi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Le Bao, Lei Yuan, Pengfei Li, Qingyun Bu, Aijun Guo, Hui Zhang, Ning Cui, Bin Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Cell Physiol Biochem Press GmbH & Co KG 2018-10-01
Edice:	Cellular Physiology and Biochemistry
Témata:	Fus LATS1/2 Hippo Hepatocellular carcinoma Metastasis Stemness
On-line přístup:	https://www.karger.com/Article/FullText/494155
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!